Understanding MTARC1: Key Component of The MTARC System (G64757)

Target Name: MTARC1

NCBI ID: G64757

MTARC1

Understanding MTARC1: Key Component of The MTARC System

Mitochondrial Transported Autoantibodies (MTARC) are a group of antibodies that are generated in the mitochondria, and they play a crucial role in the immune response. MTARC antibodies have been implicated in a number of diseases, including multiple sclerosis, autoimmune diseases, and cancer. Despite this, very little is known about theMTARC1 protein, which is a key component of theMTARC system. In this article, we will explore the MTARC1 protein, its function in the body, and its potential as a drug target or biomarker.

The MTARC system is a complex network of proteins that work together to protect the mitochondria from foreign substances. The MTARC system consists of several proteins, including MTARC1, which is a key component of the outer mitochondrial membrane (OMM) and is involved in the regulation of mitochondrial fusion and fission. MTARC1 is composed of two main regions: a transmembrane region and a cytoplasmic tail.

The transmembrane region of MTARC1 is the region that is involved in the regulation of mitochondrial fusion and fission. This region is composed of multiple transmembrane 伪-helix structures, including an 伪-helix structure, which is composed of two 尾-helix structures. The beta helix structure is formed by multiple beta hydrogen bonds, which help maintain protein stability. In addition, this region also contains an 伪-helical structure, which is composed of two 伪-helical structures. This structure helps enhance the protein's stability and maintain its function.

The cytoplasmic tail of MTARC1 is the region that is involved in the regulation of mitochondrial fusion and fission. This region is composed of a variable region and a constant region. The variable region is the region that is responsible for the recognition of foreign substances, while the constant region is the region that is responsible for the regulation of the MTARC1 protein.

MTARC1 is involved in the regulation of mitochondrial fusion and fission by interacting with several other proteins, including the protein known as p150. The p150 protein is a member of the superfamily of transmembrane proteins known as cryptodendromerin (CPT), and it is involved in a number of cellular processes, including cell signaling, DNA replication, and protein folding. MTARC1 has been shown to interact with p150 and to regulate the activity of p150.

In addition to its role in the regulation of mitochondrial fusion and fission, MTARC1 is also involved in the regulation of the immune response.MTARC1 is a key component of theMTARC system, and it is involved in the production of antibodies that are specific for foreign substances . These antibodies are then able to cross the membrane of the mitochondria and to interact with the p150 protein, which is involved in the regulation of the MTARC1 protein.

MTARC1 is also involved in the regulation of cellular signaling pathways. MTARC1 has been shown to interact with several other proteins, including the protein known as FAK. The FAK protein is a member of the Focal Adhesion kinase (FAK) family of proteins, and it is involved in a number of cellular processes, including cell signaling, migration, and invasion. MTARC1 has been shown to interact with FAK and to regulate the activity of FAK.

In addition to its role in the regulation of mitochondrial fusion and fission, MTARC1 is also involved in the regulation of the immune response by producing antibodies that are specific for foreign substances. MTARC1 is a key component of the MTARC system, and it is involved in the production of antibodies that are specific for foreign substances. These antibodies are then able to cross the membrane of the mitochondria and to interact with the p150 protein, which is involved in the regulation of the MTARC1 protein.

MTARC1 is also involved in the regulation of cellular signaling pathways by interacting with several other proteins, including the protein known as PDGFR. The PDGFR protein is a member of the platelet-derived growth factor (PDGF) family of proteins, and it is involved in a number of cellular processes, including cell signaling, angiogenesis, and immortalization. MTARC1 has been shown to interact with PDGFR and to regulate the activity of PDGFR.

In conclusion, MTARC1 is a protein that is involved in the regulation of mitochondrial fusion and fission, the immune response, and cellular signaling pathways. Its function as a drug target or biomarker makes it an attractive target for future research. Further studies are needed to fully understand theMTARC1 protein and its role in the body.

Protein Name: Mitochondrial Amidoxime Reducing Component 1

Functions: Catalyzes the reduction of N-oxygenated molecules, acting as a counterpart of cytochrome P450 and flavin-containing monooxygenases in metabolic cycles (PubMed:19053771, PubMed:21029045, PubMed:30397129). As a component of prodrug-converting system, reduces a multitude of N-hydroxylated prodrugs particularly amidoximes, leading to increased drug bioavailability (PubMed:19053771). May be involved in mitochondrial N(omega)-hydroxy-L-arginine (NOHA) reduction, regulating endogenous nitric oxide levels and biosynthesis (PubMed:21029045). Postulated to cleave the N-OH bond of N-hydroxylated substrates in concert with electron transfer from NADH to cytochrome b5 reductase then to cytochrome b5, the ultimate electron donor that primes the active site for substrate reduction (PubMed:21029045, PubMed:19053771)

The "MTARC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTARC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets